Sage Journals: Discover world-class research

Retricted access

Research article

First published 2013-6

Opioid growth factor – opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer

Ian S Zagon, Nancy K Porterfield, Patricia J McLaughlin

Experimental Biology and Medicine

Retricted access

Review article

First published 2023-12

Updated Review Article: Cyclin-Dependent Kinase 4/6 Inhibitor Impact,FDA Approval,and Resistance Pathways

Rodney J. Hunter, Jooyoung Park, Kristen J. Asprer [...]

Journal of Pharmacy Technology

Retricted access

Research article

First published 2005-05

Redox Regulation of Cell-Cycle Re-entry: Cyclin D1 as a Primary Target for the Mitogenic Effects of Reactive Oxygen and Nitrogen Species

Peter M. Burch, Nicholas H. Heintz

Antioxidants & Redox Signaling

Open access

Research article

First published 2018-4

Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells

Girolamo Spagnoletti, Valeria Li Bergolis, Annamaria Piscazzi [...]

Tumor Biology

Retricted access

Research article

First published 2012-04

Bitter Melon ( Momordica charantia ) Extract Suppresses Adrenocortical Cancer Cell Proliferation Through Modulation of the Apoptotic Pathway,Steroidogenesis,and Insulin-Like Growth Factor Type 1 Receptor/RAC-α Serine/Threonine-Protein Kinase Signaling

Victoria C. Brennan, Chiung-Min Wang, Wei-Hsiung Yang

Journal of Medicinal Food

Retricted access

Research article

First published 2013-5

Targeting the opioid growth factor: Opioid growth factor receptor axis for treatment of human ovarian cancer

Ian S Zagon, Renee Donahue, Patricia J McLaughlin

Experimental Biology and Medicine

Retricted access

Research article

First published 2019-08

Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways

Yuwei Wang, Xiao Liu, Jingshu Liu [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Other

First published 2008-8

Imiquimod Upregulates the Opioid Growth Factor Receptor to Inhibit Cell Proliferation Independent of Immune Function

Ian S. Zagon, Renee N. Donahue, Moshe Rogosnitzky [...]

Experimental Biology and Medicine

Free access

Research article

First published 2010-8

Celecoxib Inhibits β-Catenin-Dependent Survival of the Human Osteosarcoma MG-63 Cell Line

J-J Xia, L-B Pei, J-P Zhuang [...]

Journal of International Medical Research

Retricted access

Research article

First published 2011-9

Low-dose naltrexone targets the opioid growth factor–opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model

Renee N Donahue, Patricia J McLaughlin, Ian S Zagon

Experimental Biology and Medicine

Search results